Clinical Trials Browser

amivantamab × Head & Neck × 90 days × Clear all

NCT06385080 2026-06-05

OrigAMI-4

Phase 1/2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07276399 2026-06-05

OrigAMI-5

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05074940 2026-05-08

Amivantamab in Adenoid Cystic Carcinoma

Phase 2 Active not recruiting

21 enrolled 13 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms